Literature DB >> 35177883

High prevalence of prolonged QTc interval among individuals in ambulatory diabetic care in southwestern Uganda.

Richard Migisha1, David Collins Agaba1, Godfrey Katamba2, Silvia Lopez Miranda1, Anthony Muyingo3, Mark J Siedner3,4.   

Abstract

BACKGROUND: Heart rate-corrected QT (QTc) interval is associated with increased risk for cardiovascular events and mortality among individuals with diabetes mellitus (DM). Little is known about the epidemiology of prolonged QTc among people with DM in resource-limited settings.
METHODS: We conducted a cross-sectional study among adults with diabetes in ambulatory care at the Mbarara Regional Referral Hospital, from November 2018 to April 2019. Twelve-lead ECG recordings were performed on all participants. We collected clinical and laboratory data related to diabetes disease status and treatment control. We estimated QTc using Bazett's formula and categorized it according to standardized sex-adjusted thresholds. Linear regression analysis was performed to identify correlates of QTc.
RESULTS: We recruited 299 participants with a mean age of 50.1 years (SD±9.8) and mean HbA1c of 9.7 % (SD±2.6), and 69.6% were female. We detected prolonged and borderline QTc in 6.4% (19/299, 95% CI: 3.9-9.7%) and 23.4% (70/299, 95% CI: 18.7-28.6%) of participants, respectively. In multivariate models, factors associated with increasing QTc interval were mean arterial pressure (β=0.34; 95% CI: 0.07-0.63, p=0.019) and female sex (β=15.26; 95% CI: 7.58-22.94, p0.001).
CONCLUSIONS: The prevalence of abnormal QTc among individuals in routine diabetes care in southwestern Uganda was high. Female sex and mean arterial pressure were correlated with QTc interval. Given these findings, future studies should explore the clinical impact of abnormal QTc in this patient population.

Entities:  

Keywords:  Diabetes; Prevalence; QT interval; QTc dispersion; QTc prolongation; Uganda

Year:  2021        PMID: 35177883      PMCID: PMC8849522          DOI: 10.1007/s13410-021-00944-6

Source DB:  PubMed          Journal:  Int J Diabetes Dev Ctries        ISSN: 1998-3832


  27 in total

1.  Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species.

Authors:  M Wartenberg; F C Ling; M Schallenberg; A T Bäumer; K Petrat; J Hescheler; H Sauer
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

2.  Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia: effects of estrogen.

Authors:  M Griffin; H W Lee; L Zhao; M Eghbali-Webb
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

3.  Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus.

Authors:  P Rossing; L Breum; A Major-Pedersen; A Sato; H Winding; A Pietersen; J Kastrup; H H Parving
Journal:  Diabet Med       Date:  2001-03       Impact factor: 4.359

4.  QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate.

Authors:  M Veglio; R Sivieri; A Chinaglia; L Scaglione; P Cavallo-Perin
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

5.  The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity.

Authors:  Alessandra Fiorentini; Antonio Perciaccante; Rosita Valente; Alberto Paris; Pietro Serra; Luigi Tubani
Journal:  Auton Neurosci       Date:  2009-12-05       Impact factor: 3.145

6.  QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus.

Authors:  Claudia R L Cardoso; Gil F Salles; Waldemar Deccache
Journal:  Stroke       Date:  2003-07-31       Impact factor: 7.914

7.  Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.

Authors:  Lasse Oikarinen; Markku S Nieminen; Lauri Toivonen; Matti Viitasalo; Kristian Wachtell; Vasilios Papademetriou; Sverker Jern; Björn Dahlöf; Richard B Devereux; Peter M Okin
Journal:  Am Heart J       Date:  2003-05       Impact factor: 4.749

8.  Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

Authors:  Guntram Schernthaner; Chaim Lotan; Elina Baltadzhieva-Trendafilova; Jonas Ceponis; Martin Clodi; Kristine Ducena; Eva Goncalvesova; Cristian Guja; Marek Honka; Andrej Janež; Nebojša Lalić; Roger Lehmann; Noémi Nyolczas; Priit Pauklin; Andrzej Rynkiewicz; Igor Sergienko; Lea Smirčić Duvnjak
Journal:  Cardiovasc Diabetol       Date:  2018-11-21       Impact factor: 9.951

9.  Independent Influence of Blood Pressure on QTc Interval: Results from a General Chinese Population.

Authors:  Guo-Zhe Sun; Ying Zhou; Ning Ye; Shao-Jun Wu; Ying-Xian Sun
Journal:  Biomed Res Int       Date:  2019-07-08       Impact factor: 3.411

10.  Prevalence and Correlates of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes in Uganda: A Hospital-Based Cross-sectional Study.

Authors:  Richard Migisha; David Collins Agaba; Godfrey Katamba; Teddy Kwaga; Raymond Tumwesigye; Silvia Lopez Miranda; Anthony Muyingo; Mark J Siedner
Journal:  Glob Heart       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.